Dr. Lal Pathlabs Limited — Capital/Financing Update 2019

Jun 14, 2019

==> picture [288 x 42] intentionally omitted <==

June 14, 2019

National Stock Exchange of India Limited SSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Sandra Kurla Complex Dalal Street Sandra (E) Mumbai- 400001 Mumbai - 400 051.

Subject: Intimation under Regulation 30(2) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / Madam,

Please take note that the Board of Directors of Company's Wholly Owned Subsidiary viz. Pathlabs Unifiers Private Limited, in their meeting held on June, 13, 2019, approved signing a binding term sheet for acquisition of 70% equity stake in a "New Company to be incorporated' by Mrs. Vinita Kothari and Mrs. Sushila Dalal.

According to the Term Sheet, the "New Company to be incorporated"will house the business of:

1. M/s. "Central Lab, Indore" a Partnership concern having Mrs. Vinita Kothari and Mrs. Sushila Dalal as its partners and engaged in Pathology Business in the State of Madhya Pradesh.

2. M/s. "Vinita Kothari" a Proprietorship concern of Mrs. Vinita Kothari, a Histopathologist engaged in processing of Histopathology samples.

before Path Labs Unifiers Private Limited buys 70% stake of "New Company to be incorporated".

The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 are provided in the Annexure I attached to this letter.

We request you to kindly take the same on record.

Thanking You,

==> picture [180 x 101] intentionally omitted <==

==> picture [312 x 6] intentionally omitted <==

Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-JS, Rohini, New Delhi - l I0085, { +91-1 l-30258600, Fax: +91-l 1-2788-2134 Corporate Office: Dr. Lal PathLabs Ltd., 12th Floor, Tower B, SAS Tower, Medicit) Sector-38, Gurugram- 122 001, Haryana +91-124-3016-500, Fax: +91-124-4234-468

Annexure I

Sr.	Particulars in respect of the Event	Details/ Information of the Event	Details/ Information of the Event	Details/ Information of the Event
No.
1.	Name of the target entity, details in brief such as size,	Name:"NewCompany	to	be
	turnover etc.	incorporated"
		**Turnover:**As detailed in Point	No. 10
2.	Whether the acquisition would fall within related party	No, the transactionis not a	related
	transaction(s) and whether the promoter/ promoter	party transaction.
	group/ group companies have any interest in the
	entity being acquired? If yes, nature of interest and
	details thereof and whether the same is done at "arms
	length";
3.	Industry to which the entity being acquired belongs.	Healthcare/ Diagnostics
4.	Objects and efects of acquisition (including but not	TheCompany'sWholly	Owned
	limited to, disclosure of reasons for acquisition of	Subsidiaryviz.Pathlabs	Unifiers
	target entity, if its business is outside the main line of	Private Limited with the objective of
	business of the listed entity);	strengthening its business presence in
		StateofMadhyaPradesh,		India,
		decided to acquire 70% of businesses
		of
	,	1. M/s Central Lab, Indore
		(Partnership Concern) &
		2. M/s Vinita Kothari
		(Proprietorship Concern)
		through a_"New Company to be_
		incorporated".
5.	Briefdetailsofanygovernmentalorregulatory	No government approvals required
	approvals required for the acquisition
6.	Indicative time period for completion of the acquisition	Within 3 months
7.	Nature of consideration - whether cash consideration	Cash consideration
	or share swap and details of the same
8.	Cost of acquisition or the price at which the shares	Not exceeding INR 50 Crores
	are acquired
9.	Percentage of shareholding / control acquired and / or	70% equity stake in a_"New Company_
	number of shares acquired;	to be incorporated"

==> picture [159 x 76] intentionally omitted <==

	10	Brief background	Brief background	about the entity acquired in terms of	about the entity acquired in terms of	about the entity acquired in terms of	The"NewCompanytobe
		products/line	of	business	acquired,date	of	_incorporated"_will be engaged in
		incorporation,	history of last 3		years turnover, country		Healthcare / Diagnostic Services in
		in which the acquired entityother signifcant information			has presence and any		the State of Madhya Pradesh, India,and adjoining areas and shall house
							the business of:
							1.M/s"CentralLab,Indore"
							(Partnership Concern) based out of
							Indore, Madhya Pradesh.
							2.M/s"VinitaKothari"
							(sole-proprietorship Concern) based
							out of Indore, Madhya Pradesh.
							Combined turnover of M/s "Central
							Lab, Indore" and M/s "Vinita Kothari"
							for the last three financial years
							(Amount in INR Crores):
							FY17 - INR 7.55 Cr.
							FY18- INR 10.14 Cr
							FY19 - INR 13.55 Cr.